Global healthcare

March 26, 2021

Abecma Approved to Treat Multiple Myeloma

March 26, 2021 – The U.S. FDA has approved Abecma (idecabtagene vicleucel), manufactured by Bristol Myers Squibb and bluebird bio, Inc., to treat relapsed or refractory multiple
March 25, 2021

Myrbetriq Receives New Pediatric Indication

March 25, 2021 – The U.S. FDA has approved a new indication for Astellas Pharma's Myrbetriq® (mirabegron extended-release tablets) and Myrbetriq® Granules